Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Bill Aims To Dismantle PCORI, HIT Program

This article was originally published in The Pink Sheet Daily

Executive Summary

Repeal of provisions for the Patient-Centered Outcomes Research Institute and the Office of the National Coordinator for Health Information Technology is proposed by Republican House Policy Committee Chairman Thaddeus McCotter.

You may also be interested in...



OIG Criticism Of EHR Incentive Program Could Help GOP Target It In Fiscal Cliff Debate

HHS Office of Inspector General says CMS is vulnerable to making incentive payments to physicians and hospitals who self-report as meaningful users of electronic health records but may not be meeting requirements. House and Senate Republicans have been examining the incentive program, and this report could help put the program on the chopping block as Congress looks for cuts amid the fiscal cliff debate.

Delaying Medicaid Expansion Could Be Source Of Savings In Deficit Talks – Rep. Burgess

Texas Republican Congressman Burgess suggests that provisions of the Affordable Care Act, including delaying the Medicare expansion, need to be on the table to help address the budget deficit, including raising the debt ceiling.

House Committee Questions HHS On Spending Of Comparative Effectiveness Research Funds

The Energy and Commerce Committee's investigation is an example of the close scrutiny of CER activities expected of the Republican-controlled House.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071811

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel